Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 202158 in early septic shock
NCT01612676Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jun 2012
- Primary completion
- Nov 2013
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of selepressin in septic shock, sponsored by Ferring Pharmaceuticals. Started Jun 2012; status: completed.
02
Drugs
selepressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01612676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612676.